GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tchaikapharma Highquality Medicines AD (XBUL:THQM) » Definitions » Research & Development

Tchaikapharma Highquality Medicines AD (XBUL:THQM) Research & Development : лв0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Tchaikapharma Highquality Medicines AD Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Tchaikapharma Highquality Medicines AD's Research & Development for the three months ended in Mar. 2024 was лв0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was лв0.00 Mil.


Tchaikapharma Highquality Medicines AD Research & Development Historical Data

The historical data trend for Tchaikapharma Highquality Medicines AD's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tchaikapharma Highquality Medicines AD Research & Development Chart

Tchaikapharma Highquality Medicines AD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial - - - - -

Tchaikapharma Highquality Medicines AD Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Tchaikapharma Highquality Medicines AD Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was лв0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tchaikapharma Highquality Medicines AD  (XBUL:THQM) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Tchaikapharma Highquality Medicines AD Research & Development Related Terms

Thank you for viewing the detailed overview of Tchaikapharma Highquality Medicines AD's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Tchaikapharma Highquality Medicines AD (XBUL:THQM) Business Description

Traded in Other Exchanges
N/A
Address
1 G. M. Dimitrov Boulevard, Sofia, BGR, 1172
Tchaikapharma Highquality Medicines AD is engaged in the business of manufacturing and selling pharmaceuticals in Bulgaria. It manufactures medicines for cancer, heart diseases, respiratory problems, and neurological diseases, among others.

Tchaikapharma Highquality Medicines AD (XBUL:THQM) Headlines

No Headlines